HHLR ADVISORS, LTD.
Institutional investor · Portfolio as of Q4 2021
Top Holdings76 positions
BEONE MEDICINES LTD | 5.5M | $1.5B | 22.9% | $136.90 | +97.91% | 13 qtrssince 2018-Q4 | Unchanged 0 |
ON HLDG AG | 16M | $604M | 9.3% | $30.90 | +23.20% | 2 qtrssince 2021-Q3 | Unchanged 0 |
LEGEND BIOTECH CORP | 11.8M | $550.2M | 8.5% | $47.04 | +5.81% | 7 qtrssince 2020-Q2 | Increased 65 |
Salesforce Inc | 1.9M | $490.4M | 7.6% | $211.03 | +18.17% | 8 qtrssince 2020-Q1 | Increased 86 |
I MAB | 7.2M | $340.4M | 5.3% | $47.24 | +1.37% | 6 qtrssince 2020-Q3 | Unchanged 0 |
JD.COM INC | 4.8M | $334M | 5.2% | $49.36 | +29.41% | 13 qtrssince 2018-Q4 | Unchanged 0 |
Sea Ltd | 1.2M | $276.9M | 4.3% | $247.63 | -9.42% | 2 qtrssince 2021-Q3 | Increased 91 |
Doordash Inc Cl A | 1.3M | $193M | 3.0% | $142.75 | +6.75% | 5 qtrssince 2020-Q4 | Increased 57 |
IQIYI INC | 38.6M | $176.2M | 2.7% | $18.39 | -74.44% | 13 qtrssince 2018-Q4 | Unchanged 0 |
LI AUTO INC | 5M | $160.7M | 2.5% | $30.61 | +4.38% | 2 qtrssince 2021-Q3 | Increased 84 |
CYTEK BIOSCIENCES INC | 8.8M | $142.9M | 2.2% | $21.41 | -23.77% | 2 qtrssince 2021-Q3 | Unchanged 0 |
Mondelez Intl Inc Cl A | 1.9M | $123.5M | 1.9% | $33.70 | +75.79% | 13 qtrssince 2018-Q4 | Unchanged 0 |
ENFUSION INC | 5M | $104.2M | 1.6% | — | — | 1 qtr | New 68 |
KE HLDGS INC | 5M | $100.8M | 1.6% | $56.88 | -67.17% | 6 qtrssince 2020-Q3 | Unchanged 0 |
BRIDGEBIO PHARMA INC | 5.4M | $89.4M | 1.4% | $28.25 | -48.50% | 11 qtrssince 2019-Q2 | Unchanged 0 |
YATSEN HLDG LTD | 40.5M | $87M | 1.3% | $10.59 | -4.16% | 5 qtrssince 2020-Q4 | Increased 76 |
GOSSAMER BIO INC | 7.4M | $83.9M | 1.3% | $1,330.85 | -32.01% | 12 qtrssince 2019-Q1 | Unchanged 0 |
VIPSHOP HLDGS LTD | 9M | $75.3M | 1.2% | $18.58 | -59.21% | 4 qtrssince 2021-Q1 | Unchanged 0 |
ERASCA INC | 4.7M | $73.6M | 1.1% | $19.84 | -32.51% | 2 qtrssince 2021-Q3 | Unchanged 0 |
Coupang Inc Cl A | 2.4M | $71.3M | 1.1% | $28.37 | +4.28% | 2 qtrssince 2021-Q3 | Increased 52 |
HHLR ADVISORS, LTD. manages $6.5B across 76 positions as of Q4 2021. Top holdings: ONC (22.9%), ONON (9.3%), LEGN (8.5%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 2/5.0.
Active quarter - 3 new positions, 12 exits, 8 increased. Top move: SE (INCREASED, conviction 91). Portfolio: $6.5B across 76 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR